Effect of different biological response modifiers on growth and metastasizing of murine Lewis lung adenocarcinoma

International Journal of Immunotherapy

Volumn 19, Issue 2-4, 2003, Pages 141-150

  Zhanaeva, S J A ^a   Falameyeva, O V ^a   Filatova, T G ^a   Goncharova, I A ^a   Sukhenko, T G ^b   Kolesnikova, O P ^b   Kaledin, V I ^c   Korolenko, T A ^a   Nowicky, W M ^d  

^a INSTITUTE OF PHYSIOLOGY   (Russian Federation)

^b INSTITUTE OF CLINICAL IMMUNOLOGY   (Russian Federation)

^c INSTITUTE OF CYTOLOGY AND GENETICS   (Russian Federation)

^d Ukrainian Anti Cancer Institute   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BETA 1,3 GLUCAN; BIOCHEMICAL MARKER; BIOLOGICAL RESPONSE MODIFIER; CELL ENZYME; CHITOSAN DERIVATIVE; CYCLOPHOSPHAMIDE; TUMOR NECROSIS FACTOR ALPHA; UKRAIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER INHIBITION; CANCER RESISTANCE; CELL STIMULATION; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; EXPERIMENTAL NEOPLASM; FREQUENCY ANALYSIS; IN VIVO STUDY; LEWIS CARCINOMA; LUNG ADENOCARCINOMA; LUNG ALVEOLUS MACROPHAGE; LUNG METASTASIS; MALE; METASTASIS INHIBITION; MONOTHERAPY; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PROTEIN SECRETION; SOLID TUMOR; STATISTICAL SIGNIFICANCE;

EID: 6944225213     PISSN: 02559625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Uglyanitsa K.N., Nefedov L.I., Doroshenko Y.M., et al. Ukrain: a novel antitumor drug. Drugs Exptl. Clin. Res. 26(5/6), 341, 2000.
2. Kogan G. (1 →3, 1 →6)-β-D-glucans of yeasts and fungi and their biological activity. In: Atta-ur-Rahman (Ed.). " Studies in Natural Products of Chemistry, Vol. 23." Elsevier Science, Amsterdam, 2000, pp. 107-119.
3. Korolenko T.A., Svechnikova I.G., Filjushina E.E. et al. Macrophage stimulation and antitumor effect of Ukrain. Drugs Exptl. Clin. Res., 16, 253, 1998.
4. Janusz M.J., Austen K.F., Czop J.K. Lysosomal enzyme release from human monocytes by particulate activators is mediated by β-glucans inhibitable receptors. J. Immunol., 138, 3897, 1987.
5. Rasmussen L.T., Seljelid R. Novel immunomodulators with pronounced in vivo effects caused by stimulation of cytokine release. J. Cell. Biochemistry, 46, 60, 1991.
6. Di Luzio N.R. Immunopharmacology of glucan: A broad spectrum enhancer of host defense mechanisms. Trends Pharmacol. Sci., 4, 344, 1983.
7. Sakurai T., Ohno N., Yadomae T. Effects of fungal beta-glucan and interferon-gamma on the secretory functions of murine alveolar macrophages. J. Leukos. Biol., 60, 118, 1996.
8. Sherwood E.R. Enhancement IL-1 and IL-2 production by soluble glucan. Int. J. Immunopharmac., 9, 261, 1987.
9. Olson E.J., Standing J.E., Griego-Harper N., Hoffman O.A., Limper A.H. Fungal β-glucan interacts with vitronectin and stimulates tumor necrosis factor alpha release from macrophages. Infect. Immun., 64, 3548, 1996.
10. Okazaki M., Chiba N., Adachi Y., Ohno N., Yadomae T. Signal transduction pathway on beta-glucan-triggered hydrogen peroxide production by murine peritioneal macrophages in vitro. Biol. Pharm. Bull., 19, 18, 1996.
11. Flick D.A., Gifford G.E. Comparison of in vitro cytotoxic assays for tumor necrosis factor. J. Immunol. Methods, 68, 167, 1984.
12. Guo Y., He W., Boer A.M., et al. Elevated plasma chitotriosidase activity in various lysosomal storage disorders. J. Inher. Metab. Dis., 18, 717, 1995.
13. Korolenko T.A., Djanayeva S.J., Falameyeva O.V., et al. Chitotriosidase as a new marker of macrophage stimulation in a tumor model treated with cyclophosphomide and Ukrain. Drugs Exptl. Clin. Res., 26, 279, 2000.
14. Kirschke H., Barrett A.J. Chemistry of lysosomal proteases. In: Glaumann H., Ballard F.G. (Eds ). "Lysosomes: The Role in Protein Breakdown." Academic Press, London, 1987, pp, 193-238.
15. Falameyeva O.V., Poteryaeva O.N., Zhanaeva S.Y., et al. Enhancement of efficacy of Lewis lung adenocarcinoma chemotherapy with macrophage stimulator - carboxymethylated (1 -→3)-β -D-glucan. Bull. Exper. Biol. Med. (Rus.), 8, 205, 2001.
16. Artursson P., Edman P., Ericsson J.L.-E. Macrophage stimulation with some structurally related polysaccharides. Scand. J. Immunol. 25, 245, 1987.
17. Goldman R. Characteristics of the β-glucan receptor on murine macrophages. Exp Cell Res., 174, 481, 1988.
18. Michalek M., Melican D., Brunke-Reese D., et al. Activation of rat macrophages by Betafectin. PGG-glucan requires cross-linking of membrane receptors distinct from complement receptor three (CR3). J. Leukoc. Biol., 64, 337, 1998.
19. Estrada A., Yan C.H., Van Kessel A., Li B., et al. Immunomodulatory activities of oat beta-glucan in vitro and in vivo. Microbial. Immun., 41, 991, 1997.
20. Miura T., Ohno N., Miura N.N., Shimada S.M., Yadomae T. Inactivation of a particle beta-glucan by proteins in plasma and serum. Biol. Pharm. Bull., 20, 1103, 1997.
21. Yadomae T. Structure and biological activities of fungal beta-1,3-glucans. Yakugaku Zasshi., 120, 413, 2000
22. Takahashi K., Yamazaki M., Abe S. Local induction of a tumor necrosis factor (TNF)-like cytotoxic factor in murine tissues with tumorous and nontumorous inflammation after systemic administration of antitumor polysaccharides. J. Pharmacobio-Dyn., 11, 472, 1988
23. Wald M., Olejar T., Pouckova P., Zadinova M. Proteinases reduce metastatic dissemination and increase survival time in C57BI mice with the Lewis lung carcinoma. Life Sciences, 63, 237, 1998.